Quantification of cytokines on the SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform using Alpha Technology
Poster Oct 04, 2011
Caroline Cardonnel, Cathleen Salomo, Michael Katzlinger, Yvonne Fitzgerald, Cathy Olsen and Harald Hundsberger
This poster describes how Alpha Technology, a bead-based, homogeneous assay for studying molecular interactions in a microplate format, has been used to detect anti-inflammatory metabolites from cyanobacteria in human endothelial cell-based in vitro assays. Quantification of cytokines (TNF-alpha) down to picogram levels with Molecular Devices' SpectraMax® Paradigm® Modular Multi-Mode Reader is shown. Alpha Technology can be performed on the SpectraMax Paradigm Reader in various plate formats ranging from 96-well to 1536-well.
CiPA Phase 2 Study: validation of an automated microelectrode array (MEA) assay of hiPSC-derived cardiomyocyte electrophysiology for cardiac safety evaluationPoster
These results support the use of hSC-CM and MEA technology for preclinical assessment of proarrhythmic risk within the proposed CiPA paradigm, and, more generally, demonstrate that automation of the CM-MEA assay can achieve high reliability and throughput for cardiac risk assessment in vitro.READ MORE
A luminescent solar concentrator-based photomicroreactor for energy efficient continuous-flow photocatalysisPoster
The Luminescent Solar ConcentratorPhotomicroreactor
(LSC-PM) is an innovative device
for solar-powered continuous-flow photochemistry.